Mental Health
- Psychedelics in the medical toolbox?
Given the historical association of psychedelics as “recreational” mind-altering compounds within countercultures of the 1960s and 1970s, their current introduction into several aspects of medical practice is a surprise to many.
- Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Nociplastic pain is characterized by amplification of pain transmission and pain perception and does not involve visible tissue injury or damage, which makes it difficult to understand and manage.
- Psychedelics, spirituality, and existential distress in patients at the end of life
The authors explore the role of psychedelics in addressing patients’ spiritual and existential suffering at the end of life from a medical, ethical, and legal perspective.
- Reducing the risks when using benzodiazepines to treat insomnia: A public health approach
The authors review measures for preventing harm before benzodiazepines are prescribed, decreasing harm within 4 weeks after they are prescribed, and limiting harmful effects of long-term prescribing.
- A practical guide for buprenorphine initiation in the primary care setting
The authors review changes in prescribing laws and outline buprenorphine induction protocols that can be adopted in the primary care setting.
- A new paradigm for adult ADHD: A focused strategy to monitor treatment
In adults with attention deficit hyperactivity disorder, shifting the focus of treatment from reducing symptoms to increasing task completions can allow the physician and patient to quickly determine effectiveness of pharmacotherapy.
- Acute anxiety and tachycardia in a hospitalized 59-year-old woman
The patient presented with neck pain, painful swallowing, headache, and fever. She had contracted lymphoproliferative disease after liver transplant. She had stage 3 chronic kidney disease.